Yakira Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Yakira Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,995	Closed	-$473K	–	442
2021 Q1	$473K	Hold	3,995	–	–	0.1%	211
2020 Q4	$472K	Buy	+3,995	New	+$464K	0.11%	168

Yakira Capital Management's CBPO Position: Q2 2021 in Review

Yakira Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 3,995 shares — an estimated $473K sold.

Yakira Capital Management first reported a position in CBPO in Q4 2020 and held it in 2 quarters. The position peaked at $473K in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Yakira Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Yakira Capital Management sold 3,995 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $473K.
Yakira Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 2 quarters.
Yakira Capital Management's China Biologic Products Holdings, Inc. position peaked at $473K in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Yakira Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.